Mylan NV [MYL]
$18.43 0.54 (2.85%)
Market Cap 9.91 Billion
Registered in the Netherlands, Mylan is a leading generic drugmaker, with roughly 55 manufacturing and R&D facilities. Although the company was formed in 1961, the company's position as the second-largest generic company was largely attributable to the acquisition of Matrix Laboratories and generics business of Germany-based Merck KGaA. Mylan has a portfolio of more than 7,500 generic, specialty, and over-the-counter active ingredients and medicines and is predominantly recognized for manufacturing the EpiPen (treatment for anaphylaxis), which was acquired through the Merk KGaA transaction.
EPS -0.05 P/E Ratio 28.88
Previous Earnings Tue, Feb 26, 2019
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.